Showcasing Experiences with Artificial Intelligence as a New Avenue for Neurodegenerative Target Discovery
Time: 12:00 pm
day: Conference Day Two - Track One
Details:
- Demonstrating AI facilitation in the accelerated development of Vincere's pipeline of small molecules
- Analyzing clinical data to guide the optimization of drug development
- Forward-looking insights on the potential of AI technology platforms to optimize clinical trial strategies, particularly in patient stratification
